Electroporation instruments are bases on the principle of electrical conductivity of biomolecules. These instruments help generate permeability in the plasma membrane of the cell through which molecules of interest can pass through passively. Electroporation instruments help in introducing foreign proteins in different living cells. Both host cells and selected substances to be passed in those cells are mixed in a solution. Subsequently, an electric current is passed in the solution that facilitates the transfer. Electroporation instruments are used in biochemistry, biotechnology, molecular biology, and biomedical research where they allow DNA, chemicals, or drugs to be introduced in host cells.
COVID-19 Impact Analysis
- COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
- Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
- With COVID-19, the supply chain of the raw materials required to manufacture electroporation instruments has been disrupted in many countries. In addition, the market growth of electroporation instruments is declining as the manufacturers of these devices have slowed down their production due to the pandemic. Therefore, COVID 19 is expected to have a significant impact on the electroporation instruments market.
Top Impacting Factors
Rise in research activities in the field of molecular biology and biochemistry all across the world is one of the key factors boosting the growth of the electroporation instruments market.
Electroporation is often used in the biotechnology sector where it aids in the separation of proteins further aiding genetic research. Thus, rise in the number of biotechnology companies in many nations, contributes toward the market growth.
In addition, various private and public funding bodies are investing majorly in different molecular biology and biotechnology fields to come out with advancements in nanotechnology, pharmacology, and genetics. This factor boosts the growth of the electroporation instruments market.
However, stringent rules and regulations regarding the use of electroporation instruments and the dearth of skilled professionals who can handle such instruments are some of the factors that impede the growth of the electroporation instruments market.
Key Market Trends
- Increase in awareness of various electroporation instruments in the molecular biology sector is expected to boost the growth of the market during the forecast period.
- North America is anticipated to dominate the electroporation instruments market, owing to the presence of major key players and highly sophisticated research labs where electroporation instruments are often used.
- Asia-Pacific is projected to exhibit a high growth rate in the electroporation instruments market during the forecast period. This is be attributed to increase in research and development facilities in many nations of this region.
- The electroporation instruments market in Latin America and the Middle East is expected to show stagnant growth during the forecast period, due to the lack of skilled professionals and manufacturing facilities for electroporation instruments in this region.
Key Benefits of the Report
- This study presents the analytical depiction of the electroporation instruments industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the electroporation instruments market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Electroporation Instruments Report
- Which are the leading players active in the electroporation instruments market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the electroporation instruments market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps in the market?
- What are the impacts of COVID-19 on the industry?
- What are electroporation instruments?
- What are the current and predicted trends of the market?
Electroporation Instruments Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Lonza Group, Bio-Rad Laboratories, Inc, Eppendorf AG., Biotron Healthcare, Sigma-Aldrich Co. LLC, Harvard Bioscience, Inc, Thermo Fisher Scientific Inc. |
Loading Table Of Content...
